Senescence-independent SASP in HNSCC: cell and mouse-free lab study
In CAL27 HNSCC cells, dsRNA stimulation triggered an NF-κB-dependent, autophagy-dependent secretory program without classic senescence markers; it activated macrophages via IL-6, and the TLR3-autophagy-NF-κB-IL-6 signature was validated as a prognostic biomarker in oral squamous cell carcinoma. [1]
Automatic summary · not editorially reviewed
The key findings
In CAL27 cells, dsRNA stimulation triggered an NF-κB-dependent, autophagy-dependent secretory program without proliferative arrest or classic senescence markers. [1]
This SASP subtype started an IL-6-mediated cascade that activated SASP in tumor-associated macrophages. [1]
The TLR3-autophagy-NF-κB-IL-6 signature was validated as a prognostic biomarker for oral squamous cell carcinoma. [1]
The source at a glance
- Study type / format
- Laboratory study (cell culture, transcriptomic analysis, clinical specimen validation); abstract only.
- Population / context
- CAL27 head and neck squamous cell carcinoma cells, tumor-associated macrophages and clinical specimens from oral squamous cell carcinoma.
- Summary based on
- Study abstract
- Original publication
- October 5, 2026
dsRNA triggered SASP without senescence in CAL27 cells
The authors studied head and neck squamous cell carcinoma (HNSCC), which resists chemoradiotherapy and immune checkpoint inhibition. They stimulated CAL27 cells with the dsRNA mimic poly(I:C) and used chloroquine to inhibit autophagy. The stimulation produced an NF-κB-dependent secretory program they call senescence-independent SASP, without proliferative arrest or classic senescence marker expression. CXCL1 was identified as a candidate key mediator. These are cell-culture findings; the abstract does not report patient outcomes from this experiment.
Supporting source [1]
IL-6 loop to macrophages; autophagy inhibition in cells
According to the abstract, this SASP subtype started an IL-6-mediated transcellular inflammatory cascade that activated SASP in tumor-associated macrophages and remodeled the immunosuppressive tumor microenvironment. Inhibiting autophagy suppressed this SASP, reduced IL-6 secretion and disrupted the tumor-macrophage inflammatory loop. The abstract describes in vitro functional assays and integrated transcriptomic analysis; it does not report human survival results for autophagy inhibition, so this is not evidence that patients benefit.
Supporting source [1]
Prognostic signature validated in oral squamous carcinoma
Clinically, the abstract states that the TLR3-autophagy-NF-κB-IL-6 signature was validated as a reliable prognostic biomarker for oral squamous cell carcinoma, a form of HNSCC. Clinical specimen validation was part of the work. The authors propose this axis as a promising therapeutic strategy to improve chemoradiotherapy plus immunotherapy efficacy; that is a proposal, not a demonstrated treatment. The abstract does not give sample sizes, follow-up times or effect estimates, and the full text was not reviewed.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. Cell-culture and specimen work; no human trial results, sample sizes, follow-up or effect estimates are reported. The therapeutic strategy is proposed, not demonstrated.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Nan Z, Mei Y, Zhang Q, Qu X, Liu L, Zhang D. · europepmc.org · October 5, 2026